US20060105004A1 - Cosmetic compositions comprising calcium silicates - Google Patents
Cosmetic compositions comprising calcium silicates Download PDFInfo
- Publication number
- US20060105004A1 US20060105004A1 US11/320,195 US32019505A US2006105004A1 US 20060105004 A1 US20060105004 A1 US 20060105004A1 US 32019505 A US32019505 A US 32019505A US 2006105004 A1 US2006105004 A1 US 2006105004A1
- Authority
- US
- United States
- Prior art keywords
- sebum
- cosmetic composition
- skin
- composition
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 116
- 239000002537 cosmetic Substances 0.000 title claims abstract description 106
- 235000012241 calcium silicate Nutrition 0.000 title description 56
- 239000000378 calcium silicate Substances 0.000 claims abstract description 55
- 229910052918 calcium silicate Inorganic materials 0.000 claims abstract description 55
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 claims abstract description 55
- 239000012530 fluid Substances 0.000 claims abstract description 32
- 239000006210 lotion Substances 0.000 claims abstract description 23
- 239000007787 solid Substances 0.000 claims abstract description 6
- 241000195940 Bryophyta Species 0.000 claims abstract description 4
- 239000006260 foam Substances 0.000 claims abstract description 4
- 235000011929 mousse Nutrition 0.000 claims abstract description 4
- 239000007921 spray Substances 0.000 claims abstract description 4
- 239000006185 dispersion Substances 0.000 claims abstract description 3
- 239000000725 suspension Substances 0.000 claims abstract description 3
- 210000002374 sebum Anatomy 0.000 claims description 84
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- 238000010521 absorption reaction Methods 0.000 claims description 29
- 239000003921 oil Substances 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000000839 emulsion Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 18
- 229920001296 polysiloxane Polymers 0.000 claims description 15
- 125000004122 cyclic group Chemical group 0.000 claims description 11
- 239000003974 emollient agent Substances 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 8
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 239000000049 pigment Substances 0.000 claims description 7
- 239000008406 cosmetic ingredient Substances 0.000 claims description 5
- 239000000516 sunscreening agent Substances 0.000 claims description 5
- 230000000475 sunscreen effect Effects 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- 239000003605 opacifier Substances 0.000 claims description 3
- 239000002304 perfume Substances 0.000 claims description 3
- 239000004606 Fillers/Extenders Substances 0.000 claims description 2
- 239000011358 absorbing material Substances 0.000 claims description 2
- 239000012764 mineral filler Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 238000010348 incorporation Methods 0.000 claims 2
- 230000001815 facial effect Effects 0.000 abstract description 12
- 230000006866 deterioration Effects 0.000 abstract description 4
- 230000005923 long-lasting effect Effects 0.000 abstract description 4
- 238000002845 discoloration Methods 0.000 abstract description 2
- 238000005562 fading Methods 0.000 abstract description 2
- 230000002459 sustained effect Effects 0.000 abstract description 2
- 235000019198 oils Nutrition 0.000 description 26
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 25
- 239000000843 powder Substances 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 235000019441 ethanol Nutrition 0.000 description 18
- 239000004615 ingredient Substances 0.000 description 15
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 15
- 239000002245 particle Substances 0.000 description 14
- 239000002250 absorbent Substances 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- -1 semisolids Substances 0.000 description 11
- 210000001061 forehead Anatomy 0.000 description 9
- 239000000377 silicon dioxide Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 239000003981 vehicle Substances 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 230000002745 absorbent Effects 0.000 description 7
- 229960004756 ethanol Drugs 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 7
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 229940032094 squalane Drugs 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 5
- 239000008341 cosmetic lotion Substances 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 235000019698 starch Nutrition 0.000 description 5
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- 241000208680 Hamamelis mollis Species 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000002209 hydrophobic effect Effects 0.000 description 4
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000007764 o/w emulsion Substances 0.000 description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 150000004760 silicates Chemical class 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 229940118846 witch hazel Drugs 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 3
- 206010039792 Seborrhoea Diseases 0.000 description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 3
- 239000006096 absorbing agent Substances 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 229940085262 cetyl dimethicone Drugs 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 230000037312 oily skin Effects 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 229940031439 squalene Drugs 0.000 description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 2
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 2
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 238000005299 abrasion Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 229940073609 bismuth oxychloride Drugs 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- GULIJHQUYGTWSO-UHFFFAOYSA-N dodecyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCC GULIJHQUYGTWSO-UHFFFAOYSA-N 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002194 fatty esters Chemical class 0.000 description 2
- 229910021485 fumed silica Inorganic materials 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 235000013980 iron oxide Nutrition 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000011325 microbead Substances 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 2
- 229960001173 oxybenzone Drugs 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 230000036555 skin type Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940100458 steareth-21 Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- POOSGDOYLQNASK-UHFFFAOYSA-N tetracosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC POOSGDOYLQNASK-UHFFFAOYSA-N 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- UNTXZFOXVBGXGZ-UHFFFAOYSA-N 1,3,5,7,9,11,13-heptaoxa-2$l^{2},4$l^{2},6$l^{2},8$l^{2},10$l^{2},12$l^{2},14$l^{2}-heptasilacyclotetradecane Chemical compound O1[Si]O[Si]O[Si]O[Si]O[Si]O[Si]O[Si]1 UNTXZFOXVBGXGZ-UHFFFAOYSA-N 0.000 description 1
- PCRBTNZNEYJDCH-UHFFFAOYSA-N 1-tetradecoxypropan-2-yl acetate Chemical compound CCCCCCCCCCCCCCOCC(C)OC(C)=O PCRBTNZNEYJDCH-UHFFFAOYSA-N 0.000 description 1
- SAMYFBLRCRWESN-UHFFFAOYSA-N 16-methylheptadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C SAMYFBLRCRWESN-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- GRXOKLJPWSYWIA-UHFFFAOYSA-N 2-ethylhexyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CC)CCCC GRXOKLJPWSYWIA-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Chlorothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 229920006358 Fluon Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 229910000503 Na-aluminosilicate Inorganic materials 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 239000004164 Wax ester Substances 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- GANNOFFDYMSBSZ-UHFFFAOYSA-N [AlH3].[Mg] Chemical class [AlH3].[Mg] GANNOFFDYMSBSZ-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 description 1
- 229910052915 alkaline earth metal silicate Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940099583 aluminum starch octenylsuccinate Drugs 0.000 description 1
- RILYHWBPLWVCBV-UHFFFAOYSA-N aluminum;magnesium;sodium;dioxido(oxo)silane Chemical compound [Na+].[Mg+2].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O RILYHWBPLWVCBV-UHFFFAOYSA-N 0.000 description 1
- ANBBXQWFNXMHLD-UHFFFAOYSA-N aluminum;sodium;oxygen(2-) Chemical compound [O-2].[O-2].[Na+].[Al+3] ANBBXQWFNXMHLD-UHFFFAOYSA-N 0.000 description 1
- UPOYFZYFGWBUKL-UHFFFAOYSA-N amiphenazole Chemical compound S1C(N)=NC(N)=C1C1=CC=CC=C1 UPOYFZYFGWBUKL-UHFFFAOYSA-N 0.000 description 1
- 229950001798 amiphenazole Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- UHHXUPJJDHEMGX-UHFFFAOYSA-K azanium;manganese(3+);phosphonato phosphate Chemical compound [NH4+].[Mn+3].[O-]P([O-])(=O)OP([O-])([O-])=O UHHXUPJJDHEMGX-UHFFFAOYSA-K 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940114081 cinnamate Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940048300 coco-caprylate Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- DDJSWKLBKSLAAZ-UHFFFAOYSA-N cyclotetrasiloxane Chemical compound O1[SiH2]O[SiH2]O[SiH2]O[SiH2]1 DDJSWKLBKSLAAZ-UHFFFAOYSA-N 0.000 description 1
- JJRDHFIVAPVZJN-UHFFFAOYSA-N cyclotrisiloxane Chemical compound O1[SiH2]O[SiH2]O[SiH2]1 JJRDHFIVAPVZJN-UHFFFAOYSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical class O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229940100539 dibutyl adipate Drugs 0.000 description 1
- FLISWPFVWWWNNP-BQYQJAHWSA-N dihydro-3-(1-octenyl)-2,5-furandione Chemical compound CCCCCC\C=C\C1CC(=O)OC1=O FLISWPFVWWWNNP-BQYQJAHWSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- KWABLUYIOFEZOY-UHFFFAOYSA-N dioctyl butanedioate Chemical compound CCCCCCCCOC(=O)CCC(=O)OCCCCCCCC KWABLUYIOFEZOY-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 1
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229910001701 hydrotalcite Inorganic materials 0.000 description 1
- 229960001545 hydrotalcite Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- DCYOBGZUOMKFPA-UHFFFAOYSA-N iron(2+);iron(3+);octadecacyanide Chemical compound [Fe+2].[Fe+2].[Fe+2].[Fe+3].[Fe+3].[Fe+3].[Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] DCYOBGZUOMKFPA-UHFFFAOYSA-N 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 229940113915 isostearyl palmitate Drugs 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 238000002356 laser light scattering Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- HGPXWXLYXNVULB-UHFFFAOYSA-M lithium stearate Chemical compound [Li+].CCCCCCCCCCCCCCCCCC([O-])=O HGPXWXLYXNVULB-UHFFFAOYSA-M 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940105112 magnesium myristate Drugs 0.000 description 1
- DMRBHZWQMKSQGR-UHFFFAOYSA-L magnesium;tetradecanoate Chemical compound [Mg+2].CCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCC([O-])=O DMRBHZWQMKSQGR-UHFFFAOYSA-L 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- WRPMUZXHQKAAIC-CZIZESTLSA-N octadecyl (e)-octadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C\CCCCCCCC WRPMUZXHQKAAIC-CZIZESTLSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940095043 peg-4 diheptanoate Drugs 0.000 description 1
- 229940032051 peg-8 distearate Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- BFZNCPXNOGIELB-UHFFFAOYSA-N propan-2-yl 10-[5,6-dihexyl-2-(8-oxo-8-propan-2-yloxyoctyl)cyclohex-3-en-1-yl]dec-9-enoate Chemical compound CCCCCCC1C=CC(CCCCCCCC(=O)OC(C)C)C(C=CCCCCCCCC(=O)OC(C)C)C1CCCCCC BFZNCPXNOGIELB-UHFFFAOYSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 229940023566 propylene glycol myristyl ether acetate Drugs 0.000 description 1
- 229960003351 prussian blue Drugs 0.000 description 1
- 239000013225 prussian blue Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229960001866 silicon dioxide Drugs 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 230000037075 skin appearance Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910001388 sodium aluminate Inorganic materials 0.000 description 1
- 239000000429 sodium aluminium silicate Substances 0.000 description 1
- 235000012217 sodium aluminium silicate Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940098760 steareth-2 Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical compound [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- UYERRXOXXRNFHC-UHFFFAOYSA-N tridodecyl 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCC)CC(=O)OCCCCCCCCCCCC UYERRXOXXRNFHC-UHFFFAOYSA-N 0.000 description 1
- 235000013799 ultramarine blue Nutrition 0.000 description 1
- 229940124543 ultraviolet light absorber Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 238000004078 waterproofing Methods 0.000 description 1
- 235000019386 wax ester Nutrition 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229940098697 zinc laurate Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GPYYEEJOMCKTPR-UHFFFAOYSA-L zinc;dodecanoate Chemical compound [Zn+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O GPYYEEJOMCKTPR-UHFFFAOYSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/12—Face or body powders for grooming, adorning or absorbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- Skin is the largest organ of the body, accounting for almost a fifth of the weight of a normal adult.
- the skin performs the vital function of separating the internal components of the body from the outside environment, while also providing a permeable membrane to protect and maintain the internal organs.
- Sebum Located throughout the dermal layer of skin, just below its surface, are sebaceous glands, which secrete a material composed primarily of waxes and lipids, known as “sebum”. Sebum acts to moisturize the skin in order to keep it supple and firm, and yet also sufficiently flexible to accommodate the various joints and irregular contours of the body's skeleton and internal organs. Sebum is also believed to provide certain antimicrobial benefits against airborne microbes to prevent the transmission of disease from the outside environment into the body.
- sebum While sebum performs these functional skin benefits, it also affects the aesthetic appearance of the skin. For example, the most common cause of acne is a disruption in the normal, continuous flow of sebum that is typically the result of obstructed sebaceous glands. Indeed the principal objective in anti-acne therapy is to clear existing lesions and prevent the formation of new ones. An additional objective of such skin treatment is the removal of excess sebum from the skin.
- sebum can also compromise the desired facial appearance that women seek to obtain by using cosmetics, especially facial cosmetics. Women who have imperfect complexions or whose skin appears to have an oily sheen due to the accumulation of sebum often apply a layer of facial cosmetics, known commercially as foundation, or foundation makeup, in order to give the skin a more desirable appearance. However, these cosmetics absorb sebum from the skin, causing the facial cosmetic layer to either take on a shine or become darker, giving the skin a spotty, blotched appearance.
- an individual's sebum production is so high that it liquefies the cosmetic pigment layer, resulting in a rapid removal of the facial cosmetic either by physical friction and abrasion or by liquid flow.
- This problem is particularly acute on the eyelid as well as immediately below the eye. In order to avoid this it is necessary to frequently remove and reapply the cosmetic layer, which is a considerable inconvenience to most women. In order to avoid this it is necessary to frequently remove and reapply the cosmetic layer, which is a considerable inconvenience to most women.
- an individual's sebum production is so high that it liquefies the cosmetic pigment layer, resulting in a rapid removal of the facial cosmetic either by physical friction/abrasion or by liquid flow.
- This problem is particularly acute on the eyelid and/or immediately below the eye. In order to avoid this it is necessary to frequently remove and reapply the cosmetic layer, which is a considerable inconvenience to most women.
- cosmetic compositions that provide excellent coverage and a natural skin appearance while also concealing skin imperfections or protecting skin against damage from ultraviolet radiation.
- cosmetic compositions may serve as a base for such pigmented products, or can be applied over such pigmented products, thereby increasing their durability.
- cosmetic compositions may act as pure oil absorbers without the use of any other pigmented product.
- Such cosmetic compositions should be resistant to the deterioration caused by sebum and thereby provide long-lasting durability that lasts the entire day without the need for continued maintenance and reapplication. Additionally, these cosmetic compositions should have a smooth, comfortable, non-oily feeling when applied to the skin.
- mild, non-irritating cosmetic compositions that ameliorate or eliminate the affects of skin disorders, and reduce the blemishes and redness associated with acne.
- the present invention includes a cosmetic fluid composition comprising a sebum-absorbing calcium silicate, and a dispersant or carrier for the calcium silicate.
- the invention also includes a method of preparing a cosmetic composition wherein the calcium silicate is mixed with a cyclic silicone to form a premix, the premix is combined with one or more other cosmetic ingredients to form the fluid cosmetic composition.
- the present invention also includes a method for treating facial skin comprising the steps of preparing a cosmetic composition according to claim 1 , and applying the cosmetic composition to facial skin.
- FIG. 1 is a graph showing the sebum absorption comparison of Example 1.
- FIG. 2 is a graph showing the sebum absorption comparison of Example 2.
- FIG. 3 is a graph showing the sebum absorption comparison of Example 3.
- FIG. 4 is a graph showing the sebum absorption comparison of Example 4.
- FIG. 5 is a graph showing the sebum absorption comparison of Example 5.
- fluid composition it is meant a composition that contains greater than 20% by weight of one or more ingredients acceptable for use in cosmetics that are liquid at temperatures less than 100° C., such as lotions, creams, gels, semisolids, emulsions, solutions, dispersions, foams, mousses, sprays and the like.
- casual sebum level it is meant the natural sebum level of individuals before treatment with a sebum absorbing cosmetic.
- coated it is meant that the specified coating ingredient covers at least a portion of the outer surface of a particle or substrate.
- Names given to chemical substances herein generally are either accepted chemcial names, or are trade organization or regulatory agency approved names such as CTFA Adopted Names as listed in J. A. Wenninger et al., Eds., CTFA International Cosmetic Ingredient Dictionary, Eighth Ed., The Cosmetic, Toiletry and Fragrance Association, Washington, D.C., 2000.
- the present application relates to cosmetic compositions that comprise synthetic silicates, preferably calcium silicate particles.
- the silicates act as absorbents to absorb the wax and lipid-based sebum material.
- the cosmetic compositions provide effective, long-lasting facial cosmetic coverage that is highly resistant to the sebum-caused deterioration that results in the discoloration and fading typically experienced by conventional cosmetic compositions after a sustained period of use.
- the calcium silicates contained in the cosmetic compositions prepared according to the present invention rapidly absorb the sebum secreted onto the surface of the skin.
- sebum secreted onto the surface of the skin helps the skin to retain its suppleness, firmness, and moistness so that it serves as an effective permeable barrier for the body.
- the two principal components of sebum are triglycerides and wax esters (these two components make up nearly 70 wt % of sebum). Sebum also contains other lipids, fatty acids, and cholesterols.
- the high oil absorption capacity of the calcium silicates encourage the movement of the sebum into the intraparticle pores and interstices that are formed within the calcium silicates.
- the high surface area of the calcium silicates allows for the sebum to be easily adsorbed onto the surfaces of the silicate particles.
- calcium silicate is useful for absorbing sebum, as described above, when incorporated into powder cosmetics.
- calcium silicate was effective as a sebum-absorber only when present in dry form, such as in cosmetic powders, because the calcium silicate particulate surfaces and pores had to be free of liquid components and therefore available to absorb sebum.
- the present invention it has now been determined that calcium silicates having a high oil absorption capacity may also be effective in fluid composition cosmetics.
- the present calcium silicate particles are particularly suitable for use in fluid cosmetic compositions such as cremes or lotions. Because of their small particle size, they can be easily incorporated into a creme or lotion without giving it a gritty, uncomfortable feeling when applied to the skin.
- the present cosmetic fluid compositions contain sebum-absorbing calcium silicate and also a vehicle to act as a carrier or dispersant for the sebum-absorbing calcium silicate, so as to facilitate the distribution of the calcium silicate when the composition is applied to the skin.
- Suitable carriers are discussed in greater detail below.
- the cosmetic fluid compositions can be in the form of a liquid, cream, gel, semi-solid, and solid types of mixtures or emulsions, all of which form a single discrete mass of a homogeneous, uniform, and non-particulate appearance.
- At least 20 wt % of the fluid cosmetic compositions prepared according to the present invention are composed of ingredients that are liquid at temperatures below 100° C.
- the oil absorption of the sebum-absorbing calcium silicates is greater than 200 ml/100 g, preferably between 400 ml/100 g and 600 ml/100 g, most preferably around 475 ml/100 g.
- the surface area (BET) is preferably around 150 m 2 /g to 600 m 2 /g, preferably between 300 m 2 /g and 600 m 2 /g, actually between 310 m 2 /g and 350 m 2 /g.
- the particle size is preferably less than 20 microns.
- These calcium silicates are most typically prepared by the reaction of a reactive silica with an alkaline earth metal reactant, preferably an alkaline earth metal oxide or hydroxide, and a source of aluminum such as sodium aluminate or alumina. Because the final properties of the silicate are dependent on the reactivity of the silica, the silica source is preferred to be the reaction product of a soluble silicate, such as sodium silicate, and amineral acid, such as sulfuric acid.
- Suitable synthetic amorphous alkaline earth metal silicates are manufactured by the J.M. Huber Corporation and are sold in different grades under the trademark Hubersorb®. Methods and techniques for preparing these silicas are discussed in greater detail in U.S. Pat. No. 4,557,916.
- Other suitable silicates are available from J.M. Huber Corporation such as sodium aluminosilicate sold under the trademark Zeolexg and sodium magnesium aluminosilicate sold under the trademark Hydrex®.
- Polygloss® 90 a kaolin clay, Zeofree® 80 and Zeothix® 265, synthetic amorphous precipitated silicas, and Hubersorb®, 600 a calcium silicate, are available from the J. M. Huber Corporation.
- Cab-O-Sil® M5 synthetic amorphous fumed silica is available from the Cabot Corporation, Bellrica, Mass.
- Sebumase is a Magnesium Aluminum Silicate distributed by U.S. Cosmetics Corporation, Dayville, Conn.
- Synthetic sebum is a blend of oils typically found in human sebum, except that the higher molecular weight waxy compounds typically found in human sebum are omitted so that the synthetic sebum will be in liquid form at room temperature.
- the composition of synthetic liquid sebum is listed in Table III below. TABLE III Synthetic Sebum Composition Ingredient Weight, g Olive Oil 100 Oleic acid 50 Linolenic Acid 25 Squalane 25 Coconut Oil 75
- Squalane, C 30 H 62 (Tetracosane or 2,6,10,15,19,23-hexamethyl-), is (at room temperature) a liquid saturated hydrocarbon that functions as a natural emollient and is known for its unusual ability to increase the rate, depth, and extent of penetration of topical agents from medicated ointments.
- the squalane used in the present example was purchased from Arista Industries, Wilton, Conn. (Squalane should be distinguished from Squalene, C 30 H 50 , an unsaturated aliphatic hydrocarbon that is a natural component of human sebum but may also be obtained from other sources such as vegetable and fish oils. In fact, Squalane is produced by the hydrogenation of Squalene)
- the BET surface area was determined by the BET nitrogen absorption method of Brunaur et al., as reported in the J. Am. Chem. Soc. 60, 309 (1938). Bulk density is determined by weighing 100.0 grams product into a 250-mL graduated cylinder and recording the volume occupied.
- the oil absorption properties shown in table I is measured with the rubout method.
- oil is mixed with a silica and rubbed with a spatula on a smooth surface until a stiff putty-like paste is formed.
- the oil absorption value of the metasilicate the value which represents the volume of oil required per unit weight of silica to completely saturate the metasilicate absorptive capacity.
- Particle size is determined using a Model LA-910 laser light scattering instrument available from Horiba Instruments, Boothwyn, Pa.
- a laser beam is projected through a transparent cell which contains a stream of moving particles suspended in a liquid.
- Light rays which strike the particles are scattered through angles which are inversely proportional to their sizes.
- the photodetector array measures the quantity of light at several predetermined angles. Electrical signals proportional to the measured light flux values are then processed by a microcomputer system to form a multi-channel histogram of the particle size distribution.
- compositions prepared according to the present invention comprise about 0.1 wt % to about 25 wt %, preferably about 1 wt % to about 10 wt % of the sebum-absorbing calcium silicate.
- the present fluid cosmetic compositions also contain a vehicle to act as a carrier or dispersant for the calcium silicate, so as to facilitate the distribution of the calcium silicate when the composition is applied to the skin.
- Vehicles other than or in addition to water can include cosmetic astringents, liquid or solid emollients, emulsifiers, film formers, propellants, skin-conditioning agents, humectants, skin protectants, solvents, solubilizing agents, suspending agents, surfactants, sunscreen agents, ultraviolet light absorbers, waterproofing agents, viscosity increasing agents (aqueous and nonaqueous), waxes, wetting agents, and the like.
- the cosmetically acceptable vehicle will usually form from 50% to 99.9%, preferably from 80% to 90% by weight of the composition, and can, in the absence of other cosmetic adjuncts, form the balance of the composition.
- the vehicle is at least 20 wt. % water, by weight of the vehicle.
- water comprises at least 15 wt. % of the inventive composition, most preferably from 60 to 75 wt. % of the composition.
- An oil or oily material may be present, together with one or more emulsifiers to provide either a water-in-oil emulsion or an oil-in-water emulsion, depending largely on the average hydrophilic-lipophilic balance (HLB) of the emulsifiers employed.
- HLB hydrophilic-lipophilic balance
- This also includes multiple emulsions: water-in-oil-in water or an oil-in-water-in oil emulsions.
- the emulsions may contain any of a number of desired “active” ingredients, including skin colorants, drug substances (such as anti-inflammatory agents, antibiotics, topical anesthetics, antimycotics, keratolytics, etc.), skin protectants or conditioners, humectants, ultraviolet radiation absorbers, sunless tanning agents and the like, depending on the intended uses for the formulations.
- active ingredients including skin colorants, drug substances (such as anti-inflammatory agents, antibiotics, topical anesthetics, antimycotics, keratolytics, etc.), skin protectants or conditioners, humectants, ultraviolet radiation absorbers, sunless tanning agents and the like, depending on the intended uses for the formulations.
- the preferred vehicle is an emulsion containing water in amounts ranging from about 15 to 95 weight percent, preferably from about 45 to 75 percent, most preferably from about 60 percent to about 75 percent.
- Suitable emulsifiers are those known in the art for producing oil-in-water and/or water-in-oil type emulsions. Particularly preferred emulsifiers are PEG-8 Distearate available as Emerest 2712 from Henkel; Sorbitan Sesquioleate, available as Arlacel 83 and Arlacel C, Steareth-21 available as Brij 721, and Steareth-2 available as Brij 72, all from ICI Surfactants; TEA-Stearate, available as Cetasal from Gattefosse S.
- the amount of emulsifier used in the present invention is present in an amount of about 0.1 to about 10% by weight, preferably about 0.5 percent to about 5 percent by weight, most preferably about 2 percent to about 4 percent by weight
- the present cosmetic compositions will also comprise one or more dermatologically acceptable cosmetic ingredients.
- the present compositions may include sunscreens.
- Sunscreens include those materials commonly employed to block ultraviolet light.
- Illustrative compounds are the derivatives of PABA, cinnamate and salicylate.
- octyl methoxycinnamate and 2-hydroxy-4-methoxy benzophenone also known as oxybenzone
- Octyl methoxycinnamate and 2-hydroxy-4-methoxy benzophenone are commercially available under the trademarks, Parsol MCX and Benzophenone-3, respectively.
- the exact amount of sunscreen employed in the emulsions can vary depending upon the degree of protection desired from the sun's UV radiation.
- Emollients are often incorporated into cosmetic compositions of the present invention. Levels of such emollients may range from 0.5% to 50%, preferably between 5% and 30% by weight of the total composition. Emollients may be classified under such general chemical categories as esters, fatty acids and alcohols, polyols and hydrocarbons. Esters may be mono- or di-esters. Acceptable examples of fatty di-esters include dibutyl adipate, diethyl sebacate, diisopropyl dimerate, and dioctyl succinate. Acceptable branched chain fatty esters include 2-ethyl-hexyl myristate, isopropyl stearate and isostearyl palmitate.
- Acceptable tribasic acid esters include triisopropyl trilinoleate and trilauryl citrate.
- Acceptable straight chain fatty esters include lauryl palmitate, myristyl lactate, and stearyl oleate.
- Preferred esters include coco-caprylate/caprate (a blend of coco-caprylate and coco-caprate), propylene glycol myristyl ether acetate, diisopropyl adipate and cetyl octanoate.
- Suitable fatty alcohols and acids include those compounds having from 10 to 20 carbon atoms. Especially preferred are such compounds such as cetyl, myristyl, palmitic and stearyl alcohols and acids.
- polyols which may serve as emollients are linear and branched chain alkyl polyhydroxyl compounds.
- propylene glycol, sorbitol and glycerin are preferred.
- polymeric polyols such as poly-propylene glycol and polyethylene glycol.
- Butylene and propylene glycol are also especially preferred as penetration enhancers.
- Exemplary hydrocarbons which may serve as emollients are those having hydrocarbon chains anywhere from 12 to 30 carbon atoms. Specific examples include mineral oil, petroleum jelly, squalene and isoparaffins.
- thickeners are also categories of functional ingredients within the cosmetic compositions of the present invention.
- a thickener will usually be present in amounts anywhere from 0.1 to 20% by weight, preferably from about 0.5% to 10% by weight of the composition.
- Exemplary thickeners are cross-linked polyacrylate materials available under the trademark Carbopol from the B.F. Goodrich Company. Gums may be employed such as xanthan, carrageenan, gelatin, karaya, pectin and locust beans gum. Under certain circumstances the thickening function may be accomplished by a material also serving as a silicone or emollient. For instance, silicone gums in excess of 10 centistokes and esters such as glycerol stearate have dual functionality.
- Mineral fillers or extenders may be incorporated into the cosmetic composition of the invention. These include chalk, talc, kaolin, mica, sericite, starch, smectite clays, chemically modified magnesium aluminum silicate, organically modified montmorillonite clay, hydrated aluminum silicate, fumed silica, precipitated silica, colloidal silica, silica gel, hydrotalcite, corn starch, aluminum starch octenyl succinate and mixtures thereof.
- Skin feel improving components which provide good skin feel characteristics such as silica, in particular spherical silica, and silica microbeads, such as SB 150 sold by Myoshi Kasei; glass and ceramic beads sold by 3M under the name “Macrolite”; metal soaps derived from an organic carboxylic acid having from 8 to 22 carbon atoms for example zinc, magnesium or lithium stearate, zinc laurate or magnesium myristate; powders formed from non-expanded synthetic polymers, such as those formed from polyethylene, polystyrene, polyesters, polyamides (for example, Nylon or poly-.beta.-alanine); acrylate copolymers (for example, the microporous microspheres sold by Dow Corning as “Polytrap”), polymethacrylic acid, polystyrene or Teflon, such as “Fluon”; expanded powders, such as hollow micro
- suitable ingredients include sebum-absorbing materials such as starch, polyethylene, nylon, boron nitride, mica, sericite, kaolin, polymer powders including natural, synthetic, and semi-synthetic cellulose, fluorocarbon resins, polypropylene, modified starches of cellulose acetate, particulate cross-linked hydrophobic acrylate and methacrylate copolymers.
- sebum-absorbing materials such as starch, polyethylene, nylon, boron nitride, mica, sericite, kaolin, polymer powders including natural, synthetic, and semi-synthetic cellulose, fluorocarbon resins, polypropylene, modified starches of cellulose acetate, particulate cross-linked hydrophobic acrylate and methacrylate copolymers.
- cosmetically acceptable color pigments such as iron oxides, ultramarine blue, Prussian blue, manganese violet, bismuth oxychloride and FDA sanctioned CI pigments; pearling pigments (or nacreous pigments) such as bismuth oxychloride, guanine and titanium composite materials; and cosmetic preservatives such as trisodium EDTA, phenoxyethanol, ethyl alcohol, methylparaben, propylparaben, butylparaben, ethylparaben, potassium sorbate, diazolidinyl urea, and similar such compounds.
- cosmetically acceptable color pigments such as iron oxides, ultramarine blue, Prussian blue, manganese violet, bismuth oxychloride and FDA sanctioned CI pigments
- pearling pigments or nacreous pigments
- cosmetic preservatives such as trisodium EDTA, phenoxyethanol, ethyl alcohol, methylparaben, propylparab
- adjunct minor components may also be incorporated into the cosmetic compositions. These ingredients may include coloring agents, opacifiers and perfumes. Amounts of these adjunct minor components may range anywhere from 0.001% up to 20% by weight of the composition.
- the fluid cosmetic compositions additionally contain cyclic silicones.
- the cyclic silicones are deposited on the surface of the calcium silicate particles so that the cyclic silicones coat the calcium silicate particles.
- the cyclic silicones are mixed with the calcium silicate thereby depositing the cyclic silicones onto the calcium silicate particles and forming a premix. The premix is then combined with the other dermatologically-acceptable cosmetic ingredients to form a fluid cosmetic composition.
- Suitable cyclic silicones include volatile silicone polymers such as cycloheptasiloxane, cyclohexasiloxane, cyclopentasiloxane, cyclotetrasiloxane, cyclotrisiloxane and Dimethicone.
- Cosmetic compositions according to the present invention may be prepared in any form which is suitable for topical application to the skin, for example, solutions, colloidal dispersions, emulsions, suspensions, creams, lotions, gels, foams, mousses, sprays, and the like.
- the present cosmetic compositions are prepared in the form of a gel or emulsion. These cosmetic compositions may then be packaged in the form of a cream, solid stick, gel or lotion and sold to consumers.
- Example 1 of Table IV Example 1 of Table IV below along with a control for comparative purposes.
- Example 1 of Table IV Ingredient Example 1 Control 1 Talc, g 63.2 63.5 Mg Stearate, g 3.98 4.00 Nylon-12, g 1.99 2.00 Titanium Dioxide, g 7.96 8.00 Iron Oxide, g 17.91 18.00 absorbent 0.50 0.00 calcium silicate, g Methylparaben, g 0.20 0.20 Propylparaben, g 0.20 0.20 Imidazolidinyl Urea, g 0.10 0.10 PEG-4 Diheptanoate, g 3.98 4.00
- Clinical testing was performed with lipid-absorbent Sebutape® strips available from Cuderm Corporation, Dallas, Tex. The testing was performed on 20 healthy subjects of between 20 and 60 years of age. The sebum casual levels were derived from a set of Sebutape® strip readings made exactly one hour after the skin of the forehead had been thoroughly cleaned by wiping with pads soaked in 70% ethanol. After the alcohol evaporated, the strip was applied to the forehead with moderate pressure and removed after 10 seconds. The subjects were ranked as having untreated skin types ranging from “dry” to “oily”. Dry skin has low sebum concentration, corresponding to a “light” Sebutape reading of 1 point, expressed in arbitrary units. Oily skin has a high sebum concentration, corresponding to a “dark” Sebutape reading 5 points. This assured a distribution of skin types would be available for the clinical testing.
- the skin surface at the nose area of 17 available test subjects was cleaned with ethanol-soaked pads. After a 1 minute pause to allow the ethanol to evaporate the group was split into two test groups and dry cosmetic powder described above in Table IV was applied to a cotton pad and transferred directly to the cleaned skin by lightly dabbing the pad.
- the example 1 powder (which is prepared according to the present invention) was applied to nine subjects and the control 1 powder, which is free of calcium silicate and is representative of prior art powders, was applied to eight subjects.
- test strips were collected from both trials and converted to binary digital images using a flatbed scanner, and digital data obtained through the use of the scanner analyzed using ImagePro Plus 3.0 software to quantify the total spot area (number of dark pixels) on the lipid-absorbent strips.
- the greater the total dark spot area the higher the levels of sebum secreted from infundibular reservoirs, and thus higher levels of sebum concentration at the skin surface.
- lower sebum concentrations were measured on skin surfaces that had been treated with the example 1 cosmetic powder. A 10% improvement is seen with Example 1 powder containing calcium silicate over the control 1 powder.
- FIG. 1 shows the sebum absorption of example 1 powder containing calcium silicate and the sebum absorption of the control 1 powder, which contained no calcium silicate.
- Example 2 cosmetic lotion is prepared according to the present invention, while the Example 2 Control cosmetic lotion is a conventional lotion, which contains no calcium silicate.
- the lotion formulations tested are set forth in Table V below. TABLE V Example 2 Example 2 Ingredient lotion Control lotion Kelzan M Resin, g 0.3 0.31 CMC 7MF, g 0.92 0.95 calcium silicate, g 5.00 0.00 Water, g 93.88 98.74
- Kelzan M Resin is xanthan gum available from CP Kelco of Chicago, Ill.
- CMC 7MF is carboxymethyl cellulose available form Aqualon Corporation of Wilmington, Del.
- the calcium silicate is Hubersorb 600.
- treated and untreated are the spot area measurements (in pixels) darkened by sebum and total area is the total available pixel count for the entire test area, to allow a percent of the whole to be determined.
- Example 3 is a conventional water/alcohol cosmetic preparation
- Example 3 Control is also a water/alcohol preparation additionally containing witch hazel astringent
- Example 3 blank contains neither calcium silicate nor witch hazel. All three composition formulations are given in Table VI, below.
- An astringent reduces sebum secretion by closing the skin pores. This example evaluates the performance of sebum-absorbing calcium silicate versus witch hazel astringent.
- Example 3 Example Ingredient Example 3 control 3 blank Glycerin, g 2 2 2 Isopropyl Alcohol, g 20 20 20 calcium silicate, g 5.00 0.00 0 Witch Hazel, g 0.0 10.0 0 Water, g 73 68 78
- Sebutape® lipid-absorbent Sebutape® on 15 healthy subjects of between 20 and 60 years of age for two consecutive days. Foreheads were thoroughly cleaned by wiping with pads soaked in 70% ethanol and the subjects were treated with the simple water/alcohol cosmetic preparation of this invention. The water/alcohol cosmetic was applied using a sterile cotton pad. After 2 hours, Sebutape was used to measure the sebum concentration of the treated area, while the untreated area on the opposite side was used for the casual sebum level. Following a minimum of 4 hours, the subjects were then tested in the same manner described above with the other compositions described in Table VI above.
- FIG. 3 is a graphical representation of the results of the clinical tests of Example 3, Example 3 Control and Example 3 blank.
- Oil-in-water emulsion based lotions containing calcium silicate were prepared according to the present invention (the “Example 4” emulsions). A conventional oil-in-water emulsion with no calcium silicate was also prepared as the Example 4 control lotion. These formulations are given in Table VII.
- Example 4 Tradename INCI Name control
- Oil Phase Abil EM90, g Cetyl Dimethicone 2.00 2.00 Copolyol Ultrapure SAP Stearyl Alcohol 0.60 0.60 Grade, g Rita CA Cetyl Cetyl Alcohol 0.90 0.90 Alcohol, g Abil Wax 9801, g Cetyl Dimethicone 4.00 4.00 Powder Phase: Hubersorb 600, g Calcium Silicate 0.00 5.00 Water Phase: Deionized Water, g Water (Aqua) 91.50 86.50 Brij 721, g Steareth-21 1.00 1.00
- Rita CA Cetyl Alcohol is available from Rita Corporation, Woodstock, Ill.; Abil Wax 9801 and Abil EM90 are available from Goldschmidt Chemical Corporation, Hopewell, Va.; Brij 721 is available from Uniquema, Wilmington, Del.; Ultrapure SAP Grade is available from Ultra Chemical, Inc., N.J.
- An oil-in-water emulsion was prepared from the ingredient amounts given in Table VII by separately preparing a water phase and an oil phase, then combining the two phases to form an emulsion.
- the water phase is prepared by weighing water into an appropriately sized beaker and heating to 65-70° C., while keeping the beaker covered. Thereafter, Brij 721 is added to the heated water.
- the calcium silicate was added to the prepared water phase, while homogenizing with a Silverson Mixer. Mixing was continued, while the oil phase was prepared. To prepare the oil phase, combine all oil phase ingredients in a separate beaker and mix with a spatula until this oil phase appears uniform and has reached a temperature of between 70-75° C.
- Example 4 lotion which contains calcium silicate.
- the Example 4 lotion was applied using a sterile cotton pad. After 2 hours, Sebutape was used to measure the sebum concentration of the treated area, while the untreated area on the opposite side was used for the casual sebum level. After 4 hours, the same subjects were treated with the Example 4 Control lotion and Sebutape measurements were again made, as previously described. It is seen in FIG. 4 that the Example 4 control lotion actually contributed to the levels of sebum detected on the subject's skin, thus resulting in a negative “sebum improvement”. By contrast, the Example 4 lotion, which contained calcium silicate, did not contribute to the sebum levels and actually showed minor improvement over the casual sebum level.
- Example 5 lotion composition set forth below in Table VIII was prepared according to the present invention, containing calcium silicate which had been previously treated with cyclopentasiloxane.
- a calcium silicate premix was formed by mixing 75.7% SF1202 (cyclopentasiloxane from GE Silicones, General Electric Corporation, Waterford, N.Y.) with 24.3% calcium silicate.
- the cyclic silicone treatment protects the calcium silicate pores during manufacture making them available for sebum absorption after application to skin.
- TABLE VIII Ingredient Example 5 Kelzan M resin, g 0.30 CMC 7MF, g 0.95 Calcium silicate premix, g 10 Water, g 82.75
- Example 5 which contains the cyclopentasiloxane-treated calcium silicate.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Disclosed is a fluid cosmetic composition comprising a sebum-absorbing calcium silicate. These cosmetic compositions provide effective, long-lasting facial cosmetic coverage that is highly resistant to the sebum-caused deterioration that results in the discoloration and fading typically experienced by conventional cosmetic compositions after a sustained period of use. The cosmetic composition may be in the form of a creme, lotion, gel, semi-solid, dispersion, suspension, foam, mousse or spray.
Description
- This is a continuation of pending U.S. application Ser. No. 10/175,464, filed Jun. 19, 2002, the content of which is incorporated herein by reference in its entirety for all purposes.
- Skin is the largest organ of the body, accounting for almost a fifth of the weight of a normal adult. The skin performs the vital function of separating the internal components of the body from the outside environment, while also providing a permeable membrane to protect and maintain the internal organs.
- Located throughout the dermal layer of skin, just below its surface, are sebaceous glands, which secrete a material composed primarily of waxes and lipids, known as “sebum”. Sebum acts to moisturize the skin in order to keep it supple and firm, and yet also sufficiently flexible to accommodate the various joints and irregular contours of the body's skeleton and internal organs. Sebum is also believed to provide certain antimicrobial benefits against airborne microbes to prevent the transmission of disease from the outside environment into the body.
- While sebum performs these functional skin benefits, it also affects the aesthetic appearance of the skin. For example, the most common cause of acne is a disruption in the normal, continuous flow of sebum that is typically the result of obstructed sebaceous glands. Indeed the principal objective in anti-acne therapy is to clear existing lesions and prevent the formation of new ones. An additional objective of such skin treatment is the removal of excess sebum from the skin.
- In addition to contributing to the development of skin-blemishing acne, sebum can also compromise the desired facial appearance that women seek to obtain by using cosmetics, especially facial cosmetics. Women who have imperfect complexions or whose skin appears to have an oily sheen due to the accumulation of sebum often apply a layer of facial cosmetics, known commercially as foundation, or foundation makeup, in order to give the skin a more desirable appearance. However, these cosmetics absorb sebum from the skin, causing the facial cosmetic layer to either take on a shine or become darker, giving the skin a spotty, blotched appearance. In fact, in some cases, an individual's sebum production is so high that it liquefies the cosmetic pigment layer, resulting in a rapid removal of the facial cosmetic either by physical friction and abrasion or by liquid flow. This problem is particularly acute on the eyelid as well as immediately below the eye. In order to avoid this it is necessary to frequently remove and reapply the cosmetic layer, which is a considerable inconvenience to most women. In order to avoid this it is necessary to frequently remove and reapply the cosmetic layer, which is a considerable inconvenience to most women.
- In some cases, an individual's sebum production is so high that it liquefies the cosmetic pigment layer, resulting in a rapid removal of the facial cosmetic either by physical friction/abrasion or by liquid flow. This problem is particularly acute on the eyelid and/or immediately below the eye. In order to avoid this it is necessary to frequently remove and reapply the cosmetic layer, which is a considerable inconvenience to most women.
- Accordingly, there is a continuing need for cosmetic compositions that provide excellent coverage and a natural skin appearance while also concealing skin imperfections or protecting skin against damage from ultraviolet radiation. Additionally, cosmetic compositions may serve as a base for such pigmented products, or can be applied over such pigmented products, thereby increasing their durability. Alternatively, cosmetic compositions may act as pure oil absorbers without the use of any other pigmented product. Such cosmetic compositions should be resistant to the deterioration caused by sebum and thereby provide long-lasting durability that lasts the entire day without the need for continued maintenance and reapplication. Additionally, these cosmetic compositions should have a smooth, comfortable, non-oily feeling when applied to the skin. There is also a need for mild, non-irritating cosmetic compositions that ameliorate or eliminate the affects of skin disorders, and reduce the blemishes and redness associated with acne.
- The present invention includes a cosmetic fluid composition comprising a sebum-absorbing calcium silicate, and a dispersant or carrier for the calcium silicate.
- The invention also includes a method of preparing a cosmetic composition wherein the calcium silicate is mixed with a cyclic silicone to form a premix, the premix is combined with one or more other cosmetic ingredients to form the fluid cosmetic composition.
- The present invention also includes a method for treating facial skin comprising the steps of preparing a cosmetic composition according to
claim 1, and applying the cosmetic composition to facial skin. - The foregoing summary, as well as the following detailed description of preferred embodiments of the invention, will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, there is shown in the drawings embodiments which are presently preferred. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown. In the drawings:
-
FIG. 1 is a graph showing the sebum absorption comparison of Example 1. -
FIG. 2 is a graph showing the sebum absorption comparison of Example 2. -
FIG. 3 is a graph showing the sebum absorption comparison of Example 3. -
FIG. 4 is a graph showing the sebum absorption comparison of Example 4. -
FIG. 5 is a graph showing the sebum absorption comparison of Example 5. - All parts, percentages and ratios used herein are expressed by weight unless otherwise specified. All documents cited herein are incorporated by reference.
- By “fluid composition” it is meant a composition that contains greater than 20% by weight of one or more ingredients acceptable for use in cosmetics that are liquid at temperatures less than 100° C., such as lotions, creams, gels, semisolids, emulsions, solutions, dispersions, foams, mousses, sprays and the like.
- By “casual sebum level” it is meant the natural sebum level of individuals before treatment with a sebum absorbing cosmetic.
- By “coated” it is meant that the specified coating ingredient covers at least a portion of the outer surface of a particle or substrate.
- Names given to chemical substances herein generally are either accepted chemcial names, or are trade organization or regulatory agency approved names such as CTFA Adopted Names as listed in J. A. Wenninger et al., Eds., CTFA International Cosmetic Ingredient Dictionary, Eighth Ed., The Cosmetic, Toiletry and Fragrance Association, Washington, D.C., 2000.
- The present application relates to cosmetic compositions that comprise synthetic silicates, preferably calcium silicate particles. The silicates act as absorbents to absorb the wax and lipid-based sebum material. By incorporating these calcium silicates, the cosmetic compositions provide effective, long-lasting facial cosmetic coverage that is highly resistant to the sebum-caused deterioration that results in the discoloration and fading typically experienced by conventional cosmetic compositions after a sustained period of use.
- While not wishing to be limited by theory, it is believed that the calcium silicates contained in the cosmetic compositions prepared according to the present invention rapidly absorb the sebum secreted onto the surface of the skin. As discussed above, sebum secreted onto the surface of the skin helps the skin to retain its suppleness, firmness, and moistness so that it serves as an effective permeable barrier for the body. The two principal components of sebum are triglycerides and wax esters (these two components make up nearly 70 wt % of sebum). Sebum also contains other lipids, fatty acids, and cholesterols.
- The high oil absorption capacity of the calcium silicates encourage the movement of the sebum into the intraparticle pores and interstices that are formed within the calcium silicates. The high surface area of the calcium silicates allows for the sebum to be easily adsorbed onto the surfaces of the silicate particles. Thus, by incorporating these silicates into the cosmetic compositions, the resulting cosmetic compositions are more resistant to deterioration by sebum and provide more attractive, durable, long-lasting wear.
- It has been known that calcium silicate is useful for absorbing sebum, as described above, when incorporated into powder cosmetics. However, it was previously thought that calcium silicate was effective as a sebum-absorber only when present in dry form, such as in cosmetic powders, because the calcium silicate particulate surfaces and pores had to be free of liquid components and therefore available to absorb sebum. However, by the present invention it has now been determined that calcium silicates having a high oil absorption capacity may also be effective in fluid composition cosmetics. Indeed, the present calcium silicate particles are particularly suitable for use in fluid cosmetic compositions such as cremes or lotions. Because of their small particle size, they can be easily incorporated into a creme or lotion without giving it a gritty, uncomfortable feeling when applied to the skin.
- Thus, the present cosmetic fluid compositions contain sebum-absorbing calcium silicate and also a vehicle to act as a carrier or dispersant for the sebum-absorbing calcium silicate, so as to facilitate the distribution of the calcium silicate when the composition is applied to the skin. (Suitable carriers are discussed in greater detail below.) The cosmetic fluid compositions can be in the form of a liquid, cream, gel, semi-solid, and solid types of mixtures or emulsions, all of which form a single discrete mass of a homogeneous, uniform, and non-particulate appearance. At least 20 wt % of the fluid cosmetic compositions prepared according to the present invention are composed of ingredients that are liquid at temperatures below 100° C.
- Preferably the oil absorption of the sebum-absorbing calcium silicates is greater than 200 ml/100 g, preferably between 400 ml/100 g and 600 ml/100 g, most preferably around 475 ml/100 g. The surface area (BET) is preferably around 150 m2/g to 600 m2/g, preferably between 300 m2/g and 600 m2/g, actually between 310 m2/g and 350 m2/g. The particle size is preferably less than 20 microns.
- These calcium silicates are most typically prepared by the reaction of a reactive silica with an alkaline earth metal reactant, preferably an alkaline earth metal oxide or hydroxide, and a source of aluminum such as sodium aluminate or alumina. Because the final properties of the silicate are dependent on the reactivity of the silica, the silica source is preferred to be the reaction product of a soluble silicate, such as sodium silicate, and amineral acid, such as sulfuric acid. Suitable synthetic amorphous alkaline earth metal silicates are manufactured by the J.M. Huber Corporation and are sold in different grades under the trademark Hubersorb®. Methods and techniques for preparing these silicas are discussed in greater detail in U.S. Pat. No. 4,557,916. Other suitable silicates are available from J.M. Huber Corporation such as sodium aluminosilicate sold under the trademark Zeolexg and sodium magnesium aluminosilicate sold under the trademark Hydrex®.
- Physical characteristics of the calcium silicate used in the present invention, as well as the pertinent characteristics of other materials are given below in Table I.
TABLE I Physical Properties of Absorbents Specific Oil Absorption Loose Median surface Linseed oil rub- bulk particle size, area, BET, out method, density, Absorbent μm m2/g cc/100 g g/ml PolyGloss ® 90 0.4 22 42 2.6 Zeofree ® 80 14 140 200 0.14 Zeothix ® 265 4 250 220 0.10 Cab-O-Sil ® M5 9 207 189 0.04 Hubersorb ® 600 5 320 475 0.13 Sebumase 8 300 180 0.10 - Polygloss® 90, a kaolin clay, Zeofree® 80 and Zeothix® 265, synthetic amorphous precipitated silicas, and Hubersorb®, 600 a calcium silicate, are available from the J. M. Huber Corporation. Cab-O-Sil® M5 synthetic amorphous fumed silica is available from the Cabot Corporation, Bellrica, Mass. Sebumase is a Magnesium Aluminum Silicate distributed by U.S. Cosmetics Corporation, Dayville, Conn.
- The effectiveness of the calcium silicate, compared to other absorbents in absorbing hydrophobic substances (such as sebum) can be seen in Table II, below
TABLE II Oil Absorption Capacity for different hydrophobic substances Synthetic Glycerol sebum Squalane Absorbent cc/100 g cc/100 g cc/100 g Corn Starch 20 29 30 PolyGloss 90 40 45 65 Zeosyl ® TG80 incompatible 147 169 Zeofree ® 80 160 189 206 Zeithix ® 265 185 202 242 Cab-O-Sil ® M5 188 227 320 Hubersorb ® 600 245 329 373 Sebumase 221 179 267 - Zeosyl® TG80, synthetic amorphous precipitated silica treated with polydimethylsiloxane is available from J.M. Huber Corporation. Synthetic sebum is a blend of oils typically found in human sebum, except that the higher molecular weight waxy compounds typically found in human sebum are omitted so that the synthetic sebum will be in liquid form at room temperature. The composition of synthetic liquid sebum is listed in Table III below.
TABLE III Synthetic Sebum Composition Ingredient Weight, g Olive Oil 100 Oleic acid 50 Linolenic Acid 25 Squalane 25 Coconut Oil 75 - Squalane, C30H62 (Tetracosane or 2,6,10,15,19,23-hexamethyl-), is (at room temperature) a liquid saturated hydrocarbon that functions as a natural emollient and is known for its unusual ability to increase the rate, depth, and extent of penetration of topical agents from medicated ointments. The squalane used in the present example was purchased from Arista Industries, Wilton, Conn. (Squalane should be distinguished from Squalene, C30H50, an unsaturated aliphatic hydrocarbon that is a natural component of human sebum but may also be obtained from other sources such as vegetable and fish oils. In fact, Squalane is produced by the hydrogenation of Squalene)
- Where mentioned in this application, the BET surface area was determined by the BET nitrogen absorption method of Brunaur et al., as reported in the J. Am. Chem. Soc. 60, 309 (1938). Bulk density is determined by weighing 100.0 grams product into a 250-mL graduated cylinder and recording the volume occupied.
- The oil absorption properties shown in table I (and throughout this application) is measured with the rubout method. In this test, oil is mixed with a silica and rubbed with a spatula on a smooth surface until a stiff putty-like paste is formed. By measuring the quantity of oil required to have a paste mixture, which will curl when spread out, one can calculate the oil absorption value of the metasilicate, the value which represents the volume of oil required per unit weight of silica to completely saturate the metasilicate absorptive capacity. Calculation of the oil absorption value was done according to equation (I):
- Particle size is determined using a Model LA-910 laser light scattering instrument available from Horiba Instruments, Boothwyn, Pa. A laser beam is projected through a transparent cell which contains a stream of moving particles suspended in a liquid. Light rays which strike the particles are scattered through angles which are inversely proportional to their sizes. The photodetector array measures the quantity of light at several predetermined angles. Electrical signals proportional to the measured light flux values are then processed by a microcomputer system to form a multi-channel histogram of the particle size distribution.
- As can be seen in Table II, calcium silicate absorbs a far greater amount of each of these hydrophobic substances than any of the other absorbents listed in Table II. This performance is indicative of a structure that will be highly effective as a sebum micro-absorber in a cosmetic composition. Cosmetic compositions prepared according to the present invention comprise about 0.1 wt % to about 25 wt %, preferably about 1 wt % to about 10 wt % of the sebum-absorbing calcium silicate.
- As mentioned above, in addition to a sebum-absorbing calcium silicate, the present fluid cosmetic compositions also contain a vehicle to act as a carrier or dispersant for the calcium silicate, so as to facilitate the distribution of the calcium silicate when the composition is applied to the skin.
- Vehicles other than or in addition to water can include cosmetic astringents, liquid or solid emollients, emulsifiers, film formers, propellants, skin-conditioning agents, humectants, skin protectants, solvents, solubilizing agents, suspending agents, surfactants, sunscreen agents, ultraviolet light absorbers, waterproofing agents, viscosity increasing agents (aqueous and nonaqueous), waxes, wetting agents, and the like.
- The cosmetically acceptable vehicle will usually form from 50% to 99.9%, preferably from 80% to 90% by weight of the composition, and can, in the absence of other cosmetic adjuncts, form the balance of the composition. Preferably, the vehicle is at least 20 wt. % water, by weight of the vehicle. Preferably, water comprises at least 15 wt. % of the inventive composition, most preferably from 60 to 75 wt. % of the composition.
- An oil or oily material may be present, together with one or more emulsifiers to provide either a water-in-oil emulsion or an oil-in-water emulsion, depending largely on the average hydrophilic-lipophilic balance (HLB) of the emulsifiers employed. This also includes multiple emulsions: water-in-oil-in water or an oil-in-water-in oil emulsions. The emulsions may contain any of a number of desired “active” ingredients, including skin colorants, drug substances (such as anti-inflammatory agents, antibiotics, topical anesthetics, antimycotics, keratolytics, etc.), skin protectants or conditioners, humectants, ultraviolet radiation absorbers, sunless tanning agents and the like, depending on the intended uses for the formulations.
- The preferred vehicle is an emulsion containing water in amounts ranging from about 15 to 95 weight percent, preferably from about 45 to 75 percent, most preferably from about 60 percent to about 75 percent.
- Suitable emulsifiers are those known in the art for producing oil-in-water and/or water-in-oil type emulsions. Particularly preferred emulsifiers are PEG-8 Distearate available as Emerest 2712 from Henkel; Sorbitan Sesquioleate, available as Arlacel 83 and Arlacel C, Steareth-21 available as Brij 721, and Steareth-2 available as Brij 72, all from ICI Surfactants; TEA-Stearate, available as Cetasal from Gattefosse S. A; neutralized cetyl phosphate, as Amphisol A from LaRoche; Acrylate/C10-C.30 alkyl acrylate cross polymer of C10-30 alkyl acrylates and one or more monomers of acrylic acid, methacrylic acid or one of their simple esters crosslinked within allyl ether of sucrose or an allyl ether of pentaerythritol, available as Pemulen TR from B.F. Goodrich; and Cetyl Dimethicone Copolyol available as Abil EM90 from Goldschmidt Chemical Corp. The amount of emulsifier used in the present invention is present in an amount of about 0.1 to about 10% by weight, preferably about 0.5 percent to about 5 percent by weight, most preferably about 2 percent to about 4 percent by weight
- In addition to the calcium silicate and the silicate vehicle, the present cosmetic compositions will also comprise one or more dermatologically acceptable cosmetic ingredients. For example, the present compositions may include sunscreens. Sunscreens include those materials commonly employed to block ultraviolet light. Illustrative compounds are the derivatives of PABA, cinnamate and salicylate. For example, octyl methoxycinnamate and 2-hydroxy-4-methoxy benzophenone (also known as oxybenzone) can be used. Octyl methoxycinnamate and 2-hydroxy-4-methoxy benzophenone are commercially available under the trademarks, Parsol MCX and Benzophenone-3, respectively. The exact amount of sunscreen employed in the emulsions can vary depending upon the degree of protection desired from the sun's UV radiation.
- Emollients are often incorporated into cosmetic compositions of the present invention. Levels of such emollients may range from 0.5% to 50%, preferably between 5% and 30% by weight of the total composition. Emollients may be classified under such general chemical categories as esters, fatty acids and alcohols, polyols and hydrocarbons. Esters may be mono- or di-esters. Acceptable examples of fatty di-esters include dibutyl adipate, diethyl sebacate, diisopropyl dimerate, and dioctyl succinate. Acceptable branched chain fatty esters include 2-ethyl-hexyl myristate, isopropyl stearate and isostearyl palmitate. Acceptable tribasic acid esters include triisopropyl trilinoleate and trilauryl citrate. Acceptable straight chain fatty esters include lauryl palmitate, myristyl lactate, and stearyl oleate. Preferred esters include coco-caprylate/caprate (a blend of coco-caprylate and coco-caprate), propylene glycol myristyl ether acetate, diisopropyl adipate and cetyl octanoate. Suitable fatty alcohols and acids include those compounds having from 10 to 20 carbon atoms. Especially preferred are such compounds such as cetyl, myristyl, palmitic and stearyl alcohols and acids. Among the polyols which may serve as emollients are linear and branched chain alkyl polyhydroxyl compounds. For example, propylene glycol, sorbitol and glycerin are preferred. Also useful may be polymeric polyols such as poly-propylene glycol and polyethylene glycol. Butylene and propylene glycol are also especially preferred as penetration enhancers. Exemplary hydrocarbons which may serve as emollients are those having hydrocarbon chains anywhere from 12 to 30 carbon atoms. Specific examples include mineral oil, petroleum jelly, squalene and isoparaffins.
- Another category of functional ingredients within the cosmetic compositions of the present invention are thickeners. A thickener will usually be present in amounts anywhere from 0.1 to 20% by weight, preferably from about 0.5% to 10% by weight of the composition. Exemplary thickeners are cross-linked polyacrylate materials available under the trademark Carbopol from the B.F. Goodrich Company. Gums may be employed such as xanthan, carrageenan, gelatin, karaya, pectin and locust beans gum. Under certain circumstances the thickening function may be accomplished by a material also serving as a silicone or emollient. For instance, silicone gums in excess of 10 centistokes and esters such as glycerol stearate have dual functionality.
- Mineral fillers or extenders may be incorporated into the cosmetic composition of the invention. These include chalk, talc, kaolin, mica, sericite, starch, smectite clays, chemically modified magnesium aluminum silicate, organically modified montmorillonite clay, hydrated aluminum silicate, fumed silica, precipitated silica, colloidal silica, silica gel, hydrotalcite, corn starch, aluminum starch octenyl succinate and mixtures thereof.
- Other adjunct minor components may also be incorporated into the cosmetic compositions, such as skin feel components. Skin feel improving components, which provide good skin feel characteristics such as silica, in particular spherical silica, and silica microbeads, such as SB 150 sold by Myoshi Kasei; glass and ceramic beads sold by 3M under the name “Macrolite”; metal soaps derived from an organic carboxylic acid having from 8 to 22 carbon atoms for example zinc, magnesium or lithium stearate, zinc laurate or magnesium myristate; powders formed from non-expanded synthetic polymers, such as those formed from polyethylene, polystyrene, polyesters, polyamides (for example, Nylon or poly-.beta.-alanine); acrylate copolymers (for example, the microporous microspheres sold by Dow Corning as “Polytrap”), polymethacrylic acid, polystyrene or Teflon, such as “Fluon”; expanded powders, such as hollow microspheres made of thermoplastics in particular the microspheres sold as “Expancel” by Kemanord Plast or as “Micropearl F 80 ED” by Matsumoto; powders formed from natural organic materials, such as maize, wheat or rice starches, which may or may not be crosslinked, such as the powders formed from starch crosslinked by octenylsuccinic anhydride sold under the name “Dry-Flo” by National Starch; silicone resin microbeads, such as those sold as “Tospearl” by Toshiba Silicone, and their mixtures. These ingredients may include coloring agents, opacifiers and perfumes. Amounts of these other adjunct minor components may range anywhere from 0.001% up to 30% by weight of the composition.
- Other suitable ingredients include sebum-absorbing materials such as starch, polyethylene, nylon, boron nitride, mica, sericite, kaolin, polymer powders including natural, synthetic, and semi-synthetic cellulose, fluorocarbon resins, polypropylene, modified starches of cellulose acetate, particulate cross-linked hydrophobic acrylate and methacrylate copolymers.
- Also suitable are cosmetically acceptable color pigments such as iron oxides, ultramarine blue, Prussian blue, manganese violet, bismuth oxychloride and FDA sanctioned CI pigments; pearling pigments (or nacreous pigments) such as bismuth oxychloride, guanine and titanium composite materials; and cosmetic preservatives such as trisodium EDTA, phenoxyethanol, ethyl alcohol, methylparaben, propylparaben, butylparaben, ethylparaben, potassium sorbate, diazolidinyl urea, and similar such compounds.
- Other adjunct minor components may also be incorporated into the cosmetic compositions. These ingredients may include coloring agents, opacifiers and perfumes. Amounts of these adjunct minor components may range anywhere from 0.001% up to 20% by weight of the composition.
- In another embodiment of the present invention, the fluid cosmetic compositions additionally contain cyclic silicones. Preferably, the cyclic silicones are deposited on the surface of the calcium silicate particles so that the cyclic silicones coat the calcium silicate particles. Typically, the cyclic silicones are mixed with the calcium silicate thereby depositing the cyclic silicones onto the calcium silicate particles and forming a premix. The premix is then combined with the other dermatologically-acceptable cosmetic ingredients to form a fluid cosmetic composition. Suitable cyclic silicones include volatile silicone polymers such as cycloheptasiloxane, cyclohexasiloxane, cyclopentasiloxane, cyclotetrasiloxane, cyclotrisiloxane and Dimethicone.
- Cosmetic compositions according to the present invention may be prepared in any form which is suitable for topical application to the skin, for example, solutions, colloidal dispersions, emulsions, suspensions, creams, lotions, gels, foams, mousses, sprays, and the like. Preferably the present cosmetic compositions are prepared in the form of a gel or emulsion. These cosmetic compositions may then be packaged in the form of a cream, solid stick, gel or lotion and sold to consumers.
- The invention will now be described in more detail with respect to the following, specific, non-limiting examples.
- In-vivo clinical trials were done to compare the performance of two pressed facial powders. A facial pressed powder was prepared according to the present invention and is set forth as Example 1 of Table IV below along with a control for comparative purposes.
TABLE IV Ingredient Example 1 Control 1Talc, g 63.2 63.5 Mg Stearate, g 3.98 4.00 Nylon-12, g 1.99 2.00 Titanium Dioxide, g 7.96 8.00 Iron Oxide, g 17.91 18.00 absorbent 0.50 0.00 calcium silicate, g Methylparaben, g 0.20 0.20 Propylparaben, g 0.20 0.20 Imidazolidinyl Urea, g 0.10 0.10 PEG-4 Diheptanoate, g 3.98 4.00 - Clinical testing was performed with lipid-absorbent Sebutape® strips available from Cuderm Corporation, Dallas, Tex. The testing was performed on 20 healthy subjects of between 20 and 60 years of age. The sebum casual levels were derived from a set of Sebutape® strip readings made exactly one hour after the skin of the forehead had been thoroughly cleaned by wiping with pads soaked in 70% ethanol. After the alcohol evaporated, the strip was applied to the forehead with moderate pressure and removed after 10 seconds. The subjects were ranked as having untreated skin types ranging from “dry” to “oily”. Dry skin has low sebum concentration, corresponding to a “light” Sebutape reading of 1 point, expressed in arbitrary units. Oily skin has a high sebum concentration, corresponding to a “dark” Sebutape reading 5 points. This assured a distribution of skin types would be available for the clinical testing.
- Prior to the testing of the cosmetic compositions, the skin surface at the nose area of 17 available test subjects (selected from the 20 subjects evaluated above) was cleaned with ethanol-soaked pads. After a 1 minute pause to allow the ethanol to evaporate the group was split into two test groups and dry cosmetic powder described above in Table IV was applied to a cotton pad and transferred directly to the cleaned skin by lightly dabbing the pad. The example 1 powder (which is prepared according to the present invention) was applied to nine subjects and the
control 1 powder, which is free of calcium silicate and is representative of prior art powders, was applied to eight subjects. Following a period of two hours, Sebutape lipid-absorbent strips were pressed firmly against the test area of the skin for 10 seconds to determine the amount of sebum liberated from the skin at the test area. After a two hour rest period, the procedure was repeated with each subject using the alternate cosmetic test powder. Throughout the period of the study, both the outside temperature and that inside the clinic were between 15 and 21° C. - The test strips were collected from both trials and converted to binary digital images using a flatbed scanner, and digital data obtained through the use of the scanner analyzed using ImagePro Plus 3.0 software to quantify the total spot area (number of dark pixels) on the lipid-absorbent strips. The greater the total dark spot area, the higher the levels of sebum secreted from infundibular reservoirs, and thus higher levels of sebum concentration at the skin surface. In 12 of the 17 subjects, lower sebum concentrations were measured on skin surfaces that had been treated with the example 1 cosmetic powder. A 10% improvement is seen with Example 1 powder containing calcium silicate over the
control 1 powder. -
FIG. 1 shows the sebum absorption of example 1 powder containing calcium silicate and the sebum absorption of thecontrol 1 powder, which contained no calcium silicate. The sebum level for each formulation is an average of all the test subjects calculated from Sebutape pixel spot area measurements, calculated according to equation (II):
where n is the number of subjects. - The performance of the cosmetic compositions in the form of lotions were prepared according to the present invention was evaluated in a clinical test of ten healthy subjects having oily skin. The Example 2 cosmetic lotion is prepared according to the present invention, while the Example 2 Control cosmetic lotion is a conventional lotion, which contains no calcium silicate. The lotion formulations tested are set forth in Table V below.
TABLE V Example 2 Example 2 Ingredient lotion Control lotion Kelzan M Resin, g 0.3 0.31 CMC 7MF, g 0.92 0.95 calcium silicate, g 5.00 0.00 Water, g 93.88 98.74 - Kelzan M Resin is xanthan gum available from CP Kelco of Chicago, Ill. CMC 7MF is carboxymethyl cellulose available form Aqualon Corporation of Wilmington, Del. The calcium silicate is Hubersorb 600.
- Evaluations of sebum concentration were made by testing alcohol cleaned skin, allowing two hours to elapse between the application of the lotion and the measurements. Cosmetic lotions were applied directly to one side of the forehead. The untreated area on the adjacent side of the forehead was used for the casual sebum level. Measurements were made using Sebutape and the ImagePro Plus software as described above. The equations used to calculate these results are given in equation III (Example 2 Control) and equation IV (Example 2).
- Where, treated and untreated are the spot area measurements (in pixels) darkened by sebum and total area is the total available pixel count for the entire test area, to allow a percent of the whole to be determined.
- The results of this clinical test measuring sebum shown in
FIG. 2 demonstrate 36% sebum improvement for the Example 2 cosmetic lotion, which is prepared according to this invention. - The performance of the cosmetic compositions prepared according to the present invention in a simple water/alcohol cosmetic preparation was evaluated in a clinical test of fifteen subjects having oily skin. Example 3 is a conventional water/alcohol cosmetic preparation, Example 3 Control is also a water/alcohol preparation additionally containing witch hazel astringent and Example 3 blank contains neither calcium silicate nor witch hazel. All three composition formulations are given in Table VI, below. An astringent reduces sebum secretion by closing the skin pores. This example evaluates the performance of sebum-absorbing calcium silicate versus witch hazel astringent.
TABLE VI Example 3 Example Ingredient Example 3 control 3 blank Glycerin, g 2 2 2 Isopropyl Alcohol, g 20 20 20 calcium silicate, g 5.00 0.00 0 Witch Hazel, g 0.0 10.0 0 Water, g 73 68 78 - Clinical testing was performed with lipid-absorbent Sebutape® on 15 healthy subjects of between 20 and 60 years of age for two consecutive days. Foreheads were thoroughly cleaned by wiping with pads soaked in 70% ethanol and the subjects were treated with the simple water/alcohol cosmetic preparation of this invention. The water/alcohol cosmetic was applied using a sterile cotton pad. After 2 hours, Sebutape was used to measure the sebum concentration of the treated area, while the untreated area on the opposite side was used for the casual sebum level. Following a minimum of 4 hours, the subjects were then tested in the same manner described above with the other compositions described in Table VI above.
-
FIG. 3 is a graphical representation of the results of the clinical tests of Example 3, Example 3 Control and Example 3 blank. For this set of clinical trials, equation V is used to compare the average performance of each formulation to the average of the subjects' casual sebum level: - Oil-in-water emulsion based lotions containing calcium silicate were prepared according to the present invention (the “Example 4” emulsions). A conventional oil-in-water emulsion with no calcium silicate was also prepared as the Example 4 control lotion. These formulations are given in Table VII.
TABLE VII Example 4 Tradename INCI Name control Example 4 Oil Phase: Abil EM90, g Cetyl Dimethicone 2.00 2.00 Copolyol Ultrapure SAP Stearyl Alcohol 0.60 0.60 Grade, g Rita CA Cetyl Cetyl Alcohol 0.90 0.90 Alcohol, g Abil Wax 9801, g Cetyl Dimethicone 4.00 4.00 Powder Phase: Hubersorb 600, g Calcium Silicate 0.00 5.00 Water Phase: Deionized Water, g Water (Aqua) 91.50 86.50 Brij 721, g Steareth-21 1.00 1.00 - Rita CA Cetyl Alcohol is available from Rita Corporation, Woodstock, Ill.; Abil Wax 9801 and Abil EM90 are available from Goldschmidt Chemical Corporation, Hopewell, Va.; Brij 721 is available from Uniquema, Wilmington, Del.; Ultrapure SAP Grade is available from Ultra Chemical, Inc., N.J.
- An oil-in-water emulsion was prepared from the ingredient amounts given in Table VII by separately preparing a water phase and an oil phase, then combining the two phases to form an emulsion. The water phase is prepared by weighing water into an appropriately sized beaker and heating to 65-70° C., while keeping the beaker covered. Thereafter, Brij 721 is added to the heated water. The calcium silicate was added to the prepared water phase, while homogenizing with a Silverson Mixer. Mixing was continued, while the oil phase was prepared. To prepare the oil phase, combine all oil phase ingredients in a separate beaker and mix with a spatula until this oil phase appears uniform and has reached a temperature of between 70-75° C. Add the oil phase to the water phase, while continuing to homogenize, then decrease speed of mixing. After oil addition is complete, mixing was continued at a slow speed until the emulsion reached 50° C. Then it was cooled while stirring with a Lightnin mixer until the batched reached a temperature of 30° C. Thereafter, cooling was continued while stirring with a spatula until the batch reached room temperature.
- Foreheads of the test subjects were thoroughly cleaned by wiping with pads soaked in 70% ethanol and, after allowing the alcohol to evaporate, one side of the subjects' forehead was treated with the Example 4 lotion, which contains calcium silicate. The Example 4 lotion was applied using a sterile cotton pad. After 2 hours, Sebutape was used to measure the sebum concentration of the treated area, while the untreated area on the opposite side was used for the casual sebum level. After 4 hours, the same subjects were treated with the Example 4 Control lotion and Sebutape measurements were again made, as previously described. It is seen in
FIG. 4 that the Example 4 control lotion actually contributed to the levels of sebum detected on the subject's skin, thus resulting in a negative “sebum improvement”. By contrast, the Example 4 lotion, which contained calcium silicate, did not contribute to the sebum levels and actually showed minor improvement over the casual sebum level. - The performance of cosmetic lotions prepared according to the present invention was tested. The Example 5 lotion composition set forth below in Table VIII was prepared according to the present invention, containing calcium silicate which had been previously treated with cyclopentasiloxane. Specifically, a calcium silicate premix was formed by mixing 75.7% SF1202 (cyclopentasiloxane from GE Silicones, General Electric Corporation, Waterford, N.Y.) with 24.3% calcium silicate. The cyclic silicone treatment protects the calcium silicate pores during manufacture making them available for sebum absorption after application to skin.
TABLE VIII Ingredient Example 5 Kelzan M resin, g 0.30 CMC 7MF, g 0.95 Calcium silicate premix, g 10 Water, g 82.75 - Ten healthy subjects had their forehead skin cleaned with ethanol as described earlier. After the ethanol evaporated, the lotion described in Table VIII was applied to half of the forehead with the other half used to determine casual sebum levels. After 2 hours, Sebutape readings were measured, as described in previous examples. It is seen in
FIG. 5 that there is a 40% improvement in sebum levels for the Example 5 lotion, which contains the cyclopentasiloxane-treated calcium silicate. - It will be appreciated by those skilled in the art that changes could be made to the embodiments described above without departing from the broad inventive concept thereof. It is understood, therefore, that this invention is not limited to the particular embodiments disclosed, but it is intended to cover modifications within the spirit and scope of the present invention as defined by the appended claims.
Claims (20)
1. A fluid cosmetic composition comprising a sebum-absorbing calcium silicate wherein said composition is in a form selected from the group consisting of a water-based formulation, a water/alcohol-based formulation, and an emulsion, wherein if said composition is in the form of an emulsion, then said sebum-absorbing calcium silicate is present within the water phase of said emulsion, wherein said cosmetic composition further comprises at least one cosmetic ingredient selected from the group consisting of skin feel components, additional sebum absorbing materials, cosmetic preservatives, mineral fillers and extenders, color pigments, sunscreens, emollients, thickeners, opacifiers, and perfumes.
2. The fluid cosmetic composition of claim 1 , wherein the composition is in the form of a creme, lotion, gel, semi-solid, dispersion, suspension, foam, mousse or spray.
3. The fluid cosmetic composition of claim 1 , wherein said sebum-absorbing calcium silicate has an oil absorption of between 200 ml/100 g and 600 ml/100 g, and a surface area (BET) of between 150 m2/g to 600 m2/g.
4. The fluid cosmetic composition of claim 1 , wherein the sebum-absorbing calcium silicate is present in a concentration of from about 0.1 wt % to about 25 wt %.
5. The fluid cosmetic composition of claim 4 , wherein the sebum-absorbing calcium silicate is present in a concentration of from about 0.1 wt % to about 25 wt %.
6. The fluid cosmetic composition of claim 1 , wherein said composition is in the form of an emulsion and said emulsion comprises from about 0.1 wt % to 10 wt % of an emulsifier.
7. The fluid cosmetic composition of claim 1 , wherein said composition comprises from about 15 wt % to 95 wt % of water.
8. The fluid cosmetic composition of claim 1 , wherein said composition is an emulsion, and said emulsion further comprises a cyclic silicone within the oil phase of said emulsion.
9. The fluid cosmetic composition of claim 1 , wherein said sebum-absorbing calcium silicate includes a cyclic silicone deposited thereon prior to incorporation within said composition.
10. The fluid cosmetic composition of claim 5 , wherein said sebum-absorbing calcium silicate includes a cyclic silicone deposited thereon prior to incorporation within said composition.
11. A method for the absorption of sebum from human skin comprising the steps of:
a) providing a fluid cosmetic composition as described in claim 1; and
b) applying the cosmetic composition to the skin.
12. A method for the absorption of sebum from human skin comprising the steps of:
a) providing a fluid cosmetic composition as described in claim 2; and
b) applying the cosmetic composition to the skin.
13. A method for the absorption of sebum from human skin comprising the steps of:
a) providing a fluid cosmetic composition as described in claim 3; and
b) applying the cosmetic composition to the skin.
14. A method for the absorption of sebum from human skin comprising the steps of:
a) providing a fluid cosmetic composition as described in claim 4; and
b) applying the cosmetic composition to the skin.
15. A method for the absorption of sebum from human skin comprising the steps of:
a) providing a fluid cosmetic composition as described in claim 5; and
b) applying the cosmetic composition to the skin.
16. A method for the absorption of sebum from human skin comprising the steps of:
a) providing a fluid cosmetic composition as described in claim 6; and
b) applying the cosmetic composition to the skin.
17. A method for the absorption of sebum from human skin comprising the steps of:
a) providing a fluid cosmetic composition as described in claim 7; and
b) applying the cosmetic composition to the skin.
18. A method for the absorption of sebum from human skin comprising the steps of:
a) providing a fluid cosmetic composition as described in claim 8; and
b) applying the cosmetic composition to the skin.
19. A method for the absorption of sebum from human skin comprising the steps of:
a) providing a fluid cosmetic composition as described in claim 9; and
b) applying the cosmetic composition to the skin.
20. A method for the absorption of sebum from human skin comprising the steps of:
a) providing a fluid cosmetic composition as described in claim 10; and
b) applying the cosmetic composition to the skin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/320,195 US20060105004A1 (en) | 2002-06-19 | 2005-12-28 | Cosmetic compositions comprising calcium silicates |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/175,464 US7163669B2 (en) | 2002-06-19 | 2002-06-19 | Cosmetic compositions comprising calcium silicates |
US11/320,195 US20060105004A1 (en) | 2002-06-19 | 2005-12-28 | Cosmetic compositions comprising calcium silicates |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/175,464 Continuation US7163669B2 (en) | 2002-06-19 | 2002-06-19 | Cosmetic compositions comprising calcium silicates |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060105004A1 true US20060105004A1 (en) | 2006-05-18 |
Family
ID=29733871
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/175,464 Expired - Lifetime US7163669B2 (en) | 2002-06-19 | 2002-06-19 | Cosmetic compositions comprising calcium silicates |
US11/320,195 Abandoned US20060105004A1 (en) | 2002-06-19 | 2005-12-28 | Cosmetic compositions comprising calcium silicates |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/175,464 Expired - Lifetime US7163669B2 (en) | 2002-06-19 | 2002-06-19 | Cosmetic compositions comprising calcium silicates |
Country Status (6)
Country | Link |
---|---|
US (2) | US7163669B2 (en) |
EP (1) | EP1539187A4 (en) |
JP (1) | JP2005529976A (en) |
KR (1) | KR20050012805A (en) |
AU (1) | AU2003245539A1 (en) |
WO (1) | WO2004000212A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008079559A3 (en) * | 2006-12-21 | 2008-09-25 | Avon Prod Inc | Cosmetic composition containing novel fractal particle-based gels |
KR100967393B1 (en) * | 2009-12-11 | 2010-07-01 | 주식회사 위캔솔루션 | Image electronic shelf label system using multi-channel rf and multi-channel rf network performing the same |
US20160326373A1 (en) * | 2015-05-08 | 2016-11-10 | J.M. Huber Corporation | Color-Bleed Resistant Silica and Silicate Pigments and Methods of Making Same |
US9968525B2 (en) | 2007-12-27 | 2018-05-15 | Avon Products, Inc. | Optical blurring pigment composition suitable for use in cosmetics |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7163669B2 (en) * | 2002-06-19 | 2007-01-16 | J.M. Huber Corporation | Cosmetic compositions comprising calcium silicates |
US20040001794A1 (en) * | 2002-06-28 | 2004-01-01 | Withiam Michael C. | Compositions comprising odor neutralizing calcium silicate |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US20060140984A1 (en) | 2002-10-25 | 2006-06-29 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US20120156144A1 (en) * | 2002-10-25 | 2012-06-21 | Foamix | Foamable Compositions, Kits and Methods for Hyperhidrosis |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
DE602004017577D1 (en) * | 2003-02-27 | 2008-12-18 | Phares Pharm Res Nv | AMBIPHILE POROUS MATRIX |
US20050063928A1 (en) * | 2003-09-18 | 2005-03-24 | Withiam Michael C. | Compositions comprising odor neutralizing metal oxide silicates |
US7446196B2 (en) | 2004-06-03 | 2008-11-04 | Kosan Biosciences, Incorporated | Leptomycin compounds |
US20070189989A1 (en) * | 2006-02-16 | 2007-08-16 | Cantwell Maggie Y | Cosmetic compositions and methods of making and using the compositions |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US8652447B2 (en) * | 2008-12-18 | 2014-02-18 | Chevron U.S.A. Inc. | Cosmetic and personal care products containing synthetic magnesium alumino-silicate clays |
US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
CN102686205A (en) | 2009-10-02 | 2012-09-19 | 弗艾米克斯有限公司 | Topical tetracycline compositions |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
FR3015255B1 (en) * | 2013-12-23 | 2017-08-18 | Oreal | COMPOSITION COMPRISING ELASTOMERIC SILICONE FILLER, SILICONE OIL, PASTY FATTY BODY, APOLAR HYDROCARBON COMPOUND, USE AS ANTI-MIGRATION COMPOSITION |
JP2017088499A (en) | 2015-11-02 | 2017-05-25 | ロレアル | Composition comprising thermoplastic hollow particles |
CA2978573A1 (en) | 2016-09-08 | 2018-03-08 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
EP3515397B1 (en) | 2016-09-23 | 2021-06-23 | The Procter & Gamble Company | Stable foam compositions and methods of using the same to provide enhanced sensory and visual benefits to skin |
US11737960B2 (en) * | 2017-02-17 | 2023-08-29 | Imertech Sas | Use of a particulate mineral to reduce pollution |
WO2020096600A1 (en) * | 2018-11-08 | 2020-05-14 | Colgate-Palmolive Company | Deodorant compositions |
WO2023227642A1 (en) | 2022-05-27 | 2023-11-30 | Evonik Operations Gmbh | Spherical calcium silicate |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5853899A (en) * | 1996-11-04 | 1998-12-29 | Rexam Graphics Inc. | Aqueous ink receptive ink jet receiving medium yielding a water resistant ink jet print |
US6524598B2 (en) * | 2000-07-10 | 2003-02-25 | The Procter & Gamble Company | Cosmetic compositions |
US7163669B2 (en) * | 2002-06-19 | 2007-01-16 | J.M. Huber Corporation | Cosmetic compositions comprising calcium silicates |
US7303767B2 (en) * | 2005-02-03 | 2007-12-04 | J.M. Huber Corporation | Personal care compositions comprising coated/treated metal silicate absorbent particles |
US7303766B2 (en) * | 2005-02-03 | 2007-12-04 | J.M. Huber Corporation | Coated/treated metal silicate absorbent particles |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4557916A (en) | 1984-10-22 | 1985-12-10 | J. M. Huber Corporation | Synthetic calcium silicates and methods of preparation |
DE3506070A1 (en) | 1985-02-21 | 1986-08-21 | Ytong AG, 8000 München | Animal litter |
JPH0491018A (en) * | 1990-08-06 | 1992-03-24 | Kao Corp | Skin cleaner |
US5618522A (en) * | 1995-01-20 | 1997-04-08 | The Procter & Gamble Company | Emulsion compositions |
JPH11510167A (en) | 1995-07-31 | 1999-09-07 | ザ、プロクター、エンド、ギャンブル、カンパニー | Cosmetic powder composition with improved skin coverage |
US5658579A (en) | 1995-07-31 | 1997-08-19 | The Procter & Gamble Company | Cosmetic powder compositions having improved skin coverage |
JPH1036225A (en) * | 1996-07-18 | 1998-02-10 | Pola Chem Ind Inc | Water-based nail enamel |
US5780020A (en) | 1996-10-28 | 1998-07-14 | The Proctor & Gamble Company | Methods and compositions for reducing body odor |
JPH11209240A (en) * | 1998-01-20 | 1999-08-03 | Pola Chem Ind Inc | Natural looking makeup cosmetics |
JP3641138B2 (en) * | 1998-06-01 | 2005-04-20 | ポーラ化成工業株式会社 | Wrinkles and pore concealment cosmetics |
WO2000035413A1 (en) | 1998-12-15 | 2000-06-22 | The Procter & Gamble Company | Methods of absorbing body odors using silica containing body powders |
JP2001151638A (en) * | 1999-11-25 | 2001-06-05 | Pola Chem Ind Inc | Bubbling makeup-remover |
US6444745B1 (en) * | 2000-06-12 | 2002-09-03 | General Electric Company | Silicone polymer network compositions |
GB0125778D0 (en) * | 2001-10-26 | 2001-12-19 | Procter & Gamble | Silicone elastomer emulsion cosmetic composition comprising colorant inclusive internal phase |
WO2003070212A1 (en) * | 2002-02-20 | 2003-08-28 | The Procter & Gamble Company | Personal cleansing compositions |
-
2002
- 2002-06-19 US US10/175,464 patent/US7163669B2/en not_active Expired - Lifetime
-
2003
- 2003-06-18 AU AU2003245539A patent/AU2003245539A1/en not_active Abandoned
- 2003-06-18 EP EP03739164A patent/EP1539187A4/en not_active Withdrawn
- 2003-06-18 JP JP2004515843A patent/JP2005529976A/en active Pending
- 2003-06-18 KR KR10-2004-7020596A patent/KR20050012805A/en not_active Withdrawn
- 2003-06-18 WO PCT/US2003/019078 patent/WO2004000212A2/en active Application Filing
-
2005
- 2005-12-28 US US11/320,195 patent/US20060105004A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5853899A (en) * | 1996-11-04 | 1998-12-29 | Rexam Graphics Inc. | Aqueous ink receptive ink jet receiving medium yielding a water resistant ink jet print |
US6524598B2 (en) * | 2000-07-10 | 2003-02-25 | The Procter & Gamble Company | Cosmetic compositions |
US7163669B2 (en) * | 2002-06-19 | 2007-01-16 | J.M. Huber Corporation | Cosmetic compositions comprising calcium silicates |
US7303767B2 (en) * | 2005-02-03 | 2007-12-04 | J.M. Huber Corporation | Personal care compositions comprising coated/treated metal silicate absorbent particles |
US7303766B2 (en) * | 2005-02-03 | 2007-12-04 | J.M. Huber Corporation | Coated/treated metal silicate absorbent particles |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008079559A3 (en) * | 2006-12-21 | 2008-09-25 | Avon Prod Inc | Cosmetic composition containing novel fractal particle-based gels |
TWI399215B (en) * | 2006-12-21 | 2013-06-21 | Avon Prod Inc | Cosmetic composition comprising a novel gel based on FRACTAL particles |
US9345649B2 (en) | 2006-12-21 | 2016-05-24 | Avon Products, Inc. | Cosmetic composition containing novel fractal particle-based gels |
US9561163B2 (en) | 2006-12-21 | 2017-02-07 | Avon Products, Inc. | Cosmetic composition containing novel fractal particle-based gels |
US9968525B2 (en) | 2007-12-27 | 2018-05-15 | Avon Products, Inc. | Optical blurring pigment composition suitable for use in cosmetics |
KR100967393B1 (en) * | 2009-12-11 | 2010-07-01 | 주식회사 위캔솔루션 | Image electronic shelf label system using multi-channel rf and multi-channel rf network performing the same |
US20160326373A1 (en) * | 2015-05-08 | 2016-11-10 | J.M. Huber Corporation | Color-Bleed Resistant Silica and Silicate Pigments and Methods of Making Same |
US10287438B2 (en) * | 2015-05-08 | 2019-05-14 | Evonik Degussa Gmbh | Color-bleed resistant silica and silicate pigments and methods of making same |
Also Published As
Publication number | Publication date |
---|---|
EP1539187A4 (en) | 2006-12-13 |
JP2005529976A (en) | 2005-10-06 |
AU2003245539A1 (en) | 2004-01-06 |
AU2003245539A8 (en) | 2004-01-06 |
EP1539187A2 (en) | 2005-06-15 |
US7163669B2 (en) | 2007-01-16 |
US20030235597A1 (en) | 2003-12-25 |
KR20050012805A (en) | 2005-02-02 |
WO2004000212A2 (en) | 2003-12-31 |
WO2004000212A3 (en) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7163669B2 (en) | Cosmetic compositions comprising calcium silicates | |
US6258345B1 (en) | Stable topical composition comprising a solid elastomeric organopolysiloxane and spherical particles | |
US10064810B2 (en) | Matte cosmetic compositions | |
US7407666B2 (en) | Linear silicone resins in personal care applications | |
US5393526A (en) | Cosmetic compositions | |
US20040180032A1 (en) | Long wearing cosmetic composition | |
US20080031834A1 (en) | Cosmetic Compositions | |
EP1909749B1 (en) | Cosmetic composition for skin care | |
JPH0745375B2 (en) | Cosmetic composition | |
US20150313812A1 (en) | Matte Cosmetic Compositions | |
JPH1029910A (en) | Cosmetic material | |
EP2000177A2 (en) | Cosmetic compositions containing a propylphenylsilsesquioxane resin and a cosmetically-acceptable aromatic solvent | |
US20030077240A1 (en) | Use of high-purity phenylsilsesquioxane liquids for the preparation of cosmetic and pharmaceutical compositions | |
US20040156806A1 (en) | Cosmetic compositions containing siloxane resins | |
US20050089498A1 (en) | Cosmetic compositions containing first and second film forming polymers | |
EP1166745B1 (en) | Cosmetics containing polysaccharide-sterol derivatives | |
US20030190300A1 (en) | Cosmetic compositions containing meadowsweet extract and methods for treating skin | |
US20220040067A1 (en) | Matt-effect cosmetic composition | |
US6228377B1 (en) | Water-in-oil emulsion containing fused silica and a polysaccharide alkyl ether | |
US6235297B1 (en) | Methods for treating skin with 3-hydroxy benzoic acid and related compositions | |
JP4637425B2 (en) | Oily cosmetics | |
EP2174691A1 (en) | Cosmetic core stick with a water based hard core part | |
US20100008882A1 (en) | Silicone polyester resins in personal care applications | |
JP3663535B2 (en) | Powder cosmetics | |
US20030124081A1 (en) | Stable topical composition comprising a solid elastomeric organopolysiloxane and spherical particles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |